These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26500515)

  • 1. Timing of therapies for Down syndrome: the sooner, the better.
    Stagni F; Giacomini A; Guidi S; Ciani E; Bartesaghi R
    Front Behav Neurosci; 2015; 9():265. PubMed ID: 26500515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
    Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
    Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty Acids: A Safe Tool for Improving Neurodevelopmental Alterations in Down Syndrome?
    Martínez-Cué C; Bartesaghi R
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives.
    Stagni F; Bartesaghi R
    Front Cell Neurosci; 2022; 16():903729. PubMed ID: 35634470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it possible to improve neurodevelopmental abnormalities in Down syndrome?
    Bartesaghi R; Guidi S; Ciani E
    Rev Neurosci; 2011; 22(4):419-55. PubMed ID: 21819263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
    Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
    Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurogenesis impairment: An early developmental defect in Down syndrome.
    Stagni F; Giacomini A; Emili M; Guidi S; Bartesaghi R
    Free Radic Biol Med; 2018 Jan; 114():15-32. PubMed ID: 28756311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome.
    Uguagliati B; Al-Absi AR; Stagni F; Emili M; Giacomini A; Guidi S; Nyengaard JR; Bartesaghi R
    Hippocampus; 2021 Apr; 31(4):435-447. PubMed ID: 33464704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Appearance of Dendritic Alterations in Neocortical Pyramidal Neurons of the Ts65Dn Model of Down Syndrome.
    Uguagliati B; Stagni F; Emili M; Giacomini A; Russo C; Guidi S; Bartesaghi R
    Dev Neurosci; 2022; 44(1):23-38. PubMed ID: 34852343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Uguagliati B; Bonasoni MP; Bartesaghi R; Guidi S
    Brain Pathol; 2019 May; 29(3):366-379. PubMed ID: 30325080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome.
    Contestabile A; Benfenati F; Gasparini L
    Prog Neurobiol; 2010 May; 91(1):1-22. PubMed ID: 20097253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome.
    Emili M; Stagni F; Salvalai ME; Uguagliati B; Giacomini A; Albac C; Potier MC; Grilli M; Bartesaghi R; Guidi S
    Neurobiol Dis; 2020 Jul; 140():104874. PubMed ID: 32325119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
    Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome.
    Stagni F; Salvalai ME; Giacomini A; Emili M; Uguagliati B; Xia E; Grilli M; Bartesaghi R; Guidi S
    Neurobiol Dis; 2019 Sep; 129():44-55. PubMed ID: 31085229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Trazzi S; Fuchs C; De Franceschi M; Mitrugno VM; Bartesaghi R; Ciani E
    Neurobiol Dis; 2014 Jul; 67():24-36. PubMed ID: 24636797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome.
    Rueda N; Flórez J; Dierssen M; Martínez-Cué C
    Prog Brain Res; 2020; 251():245-268. PubMed ID: 32057309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
    Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Raspanti A; Giacomini A; Guidi S; Emili M; Ciani E; Giuliani A; Bighinati A; Calzà L; Magistretti J; Bartesaghi R
    Neurobiol Dis; 2017 Jul; 103():11-23. PubMed ID: 28359846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.